121 related articles for article (PubMed ID: 1521238)
1. Trisomy of chromosome 8 in myelodysplastic syndrome. Significance of the fluctuating trisomy 8 population.
Iwabuchi A; Ohyashiki K; Ohyashiki JH; Sasao I; Murakami T; Kodama A; Toyama K
Cancer Genet Cytogenet; 1992 Aug; 62(1):70-4. PubMed ID: 1521238
[TBL] [Abstract][Full Text] [Related]
2. Clonal cell lineage involvement in myelodysplastic syndromes studied by fluorescence in situ hybridization and morphology.
Bernell P; Jacobsson B; Nordgren A; Hast R
Leukemia; 1996 Apr; 10(4):662-8. PubMed ID: 8618444
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of trisomy 8 as a single anomaly and the influence of additional cytogenetic aberrations in primary myelodysplastic syndromes.
Saumell S; Florensa L; Luño E; Sanzo C; Cañizo C; Hernández JM; Cervera J; Gallart MA; Carbonell F; Collado R; Arenillas L; Pedro C; Bargay J; Nomdedeu B; Xicoy B; Vallespí T; Raya JM; Belloch L; Sanz GF; Solé F
Br J Haematol; 2012 Nov; 159(3):311-21. PubMed ID: 22958186
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of lineage involvement by trisomy 8 in myelodysplastic syndrome. A multiparameter analysis combining conventional cytogenetics, DNA in situ hybridization, and bone marrow culture studies.
Fagioli F; Cuneo A; Bardi A; Carli MG; Bigoni R; Balsamo R; Previati R; Pazzi I; Roberti G; Rigolin GM
Cancer Genet Cytogenet; 1995 Jul; 82(2):116-22. PubMed ID: 7664240
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of detection of trisomy 8 with fluorescence in situ hybridization and conventional karyotype analysis in myelodysplastic syndrome].
Zhang ZB; Liu SH; Li J; Bo LJ; Cui HY; Liu XP; Nie YX; Qin S
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Apr; 10(2):115-8. PubMed ID: 12513811
[TBL] [Abstract][Full Text] [Related]
6. [Aberrations of chromosome 8 in myelodysplastic syndromes: clinical and biological significance].
Marisavljević D; Pantić-Ludoski M; Novak A; Djordjević V
Srp Arh Celok Lek; 2006; 134(9-10):404-7. PubMed ID: 17252907
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory disorders associated with trisomy 8-myelodysplastic syndromes: French retrospective case-control study.
Wesner N; Drevon L; Guedon A; Fraison JB; Trad S; Kahn JE; Aouba A; Gillard J; Ponsoye M; Hanslik T; Gourguechon C; Liozon E; Laribi K; Rossignol J; Hermine O; Adès L; Carrat F; Fenaux P; Mekinian A; Fain O;
Eur J Haematol; 2019 Jan; 102(1):63-69. PubMed ID: 30218579
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil dysplasia is not a specific feature of the abnormal chromosomal clone in myelodysplastic syndromes.
Hast R; Eriksson M; Widell S; Arvidsson I; Bemell P
Leuk Res; 1999 Jun; 23(6):579-84. PubMed ID: 10374851
[TBL] [Abstract][Full Text] [Related]
9. [Cytogenetic characteristics of hematopoietic and stromal progenitor cells in myelodysplastic syndrome].
Pimenova MA; Parovichnikova EN; Kokhno AV; Domracheva EV; Manakova TE; Mal'tseva IuS; Konnova ML; Shishigina LA; Savchenko VG
Ter Arkh; 2013; 85(7):34-42. PubMed ID: 24137945
[TBL] [Abstract][Full Text] [Related]
10. Clinical impact of the clone size in MDS cases with monosomy 7 or 7q deletion, trisomy 8, 20q deletion and loss of Y chromosome.
Mallo M; Luño E; Sanzo C; Cervera J; Haase D; Schanz J; García-Manero G; del Cañizo C; Sanz GF; Solé F
Leuk Res; 2011 Jun; 35(6):834-6. PubMed ID: 21269692
[TBL] [Abstract][Full Text] [Related]
11. Paroxysmal nocturnal haemoglobinuria clones in patients with myelodysplastic syndromes.
Iwanaga M; Furukawa K; Amenomori T; Mori H; Nakamura H; Fuchigami K; Kamihira S; Nakakuma H; Tomonaga M
Br J Haematol; 1998 Jul; 102(2):465-74. PubMed ID: 9695961
[TBL] [Abstract][Full Text] [Related]
12. Dyspoietic changes associated with hepatosplenic T-cell lymphoma are not a manifestation of a myelodysplastic syndrome: analysis of 25 patients.
Yabe M; Medeiros LJ; Tang G; Wang SA; P Patel K; Routbort M; Bhagat G; Bueso-Ramos CE; Jorgensen JL; Luthra R; Chen W; Muzzafar T; Kanagal-Shamanna R; Khoury JD; Daneshbod Y; Davanlou M; Li S; Young KH; Miranda RN
Hum Pathol; 2016 Apr; 50():109-17. PubMed ID: 26997444
[TBL] [Abstract][Full Text] [Related]
13. Consecutive chromosomal studies in patients with myelodysplastic syndrome (MDS). Czechoslovak MDS Cooperative Group.
Michalova K; Musilova J; Zemanova Z
Ann Genet; 1991; 34(3-4):212-8. PubMed ID: 1809229
[TBL] [Abstract][Full Text] [Related]
14. Myelodysplastic syndrome in a child with constitutional trisomy 8 mosaicism and normal phenotype.
Hasle H; Clausen N; Pedersen B; Bendix-Hansen K
Cancer Genet Cytogenet; 1995 Jan; 79(1):79-81. PubMed ID: 7850757
[TBL] [Abstract][Full Text] [Related]
15. [Detection of trisomy 8 with interphase fluorescence in situ hybridization in myelodysplastic syndromes].
Li J; Pan J; Xue Y; Wu C; Xie X; Guo Y; Ruan C
Zhonghua Xue Ye Xue Za Zhi; 2000 Apr; 21(4):179-81. PubMed ID: 11876976
[TBL] [Abstract][Full Text] [Related]
16. High-resolution genome-wide array-based comparative genome hybridization reveals cryptic chromosome changes in AML and MDS cases with trisomy 8 as the sole cytogenetic aberration.
Paulsson K; Heidenblad M; Strömbeck B; Staaf J; Jönsson G; Borg A; Fioretos T; Johansson B
Leukemia; 2006 May; 20(5):840-6. PubMed ID: 16498392
[TBL] [Abstract][Full Text] [Related]
17. Myelodysplastic syndrome with trisomy 11 associated with polycythemia vera.
Ohyashiki K; Nagasu M; Hojo H; Iwabuchi A; Ohyashiki JH; Toyama K
Am J Hematol; 1989 Jun; 31(2):122-5. PubMed ID: 2735317
[TBL] [Abstract][Full Text] [Related]
18. Study of clonality in myelodysplastic syndromes: detection of trisomy 8 in bone marrow cell smears by fluorescence in situ hybridization.
Abruzzese E; Buss D; Rainer R; Rao PN; Pettenati MJ
Leuk Res; 1996 Jul; 20(7):551-7. PubMed ID: 8795688
[TBL] [Abstract][Full Text] [Related]
19. Directed therapy for patients with myelodysplastic syndromes (MDS) by suppression of cyclin D1 with ON 01910.Na.
Olnes MJ; Shenoy A; Weinstein B; Pfannes L; Loeliger K; Tucker Z; Tian X; Kwak M; Wilhelm F; Yong AS; Maric I; Maniar M; Scheinberg P; Groopman J; Young NS; Sloand EM
Leuk Res; 2012 Aug; 36(8):982-9. PubMed ID: 22524974
[TBL] [Abstract][Full Text] [Related]
20. Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype.
Cuneo A; Bigoni R; Cavazzini F; Bardi A; Roberti MG; Agostini P; Tammiso E; Ciccone N; Mancini M; Nanni M; De Cuia R; Divona M; La Starza R; Crescenzi B; Testoni N; Rege Cambrin G; Mecucci C; Lo Coco F; Saglio G; Castoldi G
Leukemia; 2002 Sep; 16(9):1745-51. PubMed ID: 12200689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
